Early Treatment of Diabetic Retinopathy

Diabetic Retinopathy

Impact of Diabetes and DR

Impact of Diabetes and DR (cont)

DR/PDR Risk Factors

Hyperglycemia and DR

DR Visual Symptoms

Recommended Eye Exams for Patients With Diabetes

Diabetes Control and Complications Trial (DCCT) Study Design

Diabetes Control and Complications Trial (DCCT) Results

Epidemiology of Diabetes Interventions and Complications (EDIC)

ACCORD Eye Study

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Ophthamology Substudy

Public Health Recommendations

Multidisciplinary Approach

PANORAMA Study Design

PANORAMA Results

PANORAMA Mean Changes in BCVA and CRT

PANORAMA VTC or CI-DME Through Week 52

PANORAMA Ocular TEAEs Through Week 52

VIVID and VISTA Study Design

VIVID and VISTA Patients With ≥ 2-Step Improvement in DRSS

VIVID and VISTA Post-Hoc Analysis

RISE and RIDE Long-Term Open-Label Extension With Ranibizumab

Ranibizumab

Protocol S Ranibizumab for PDR

Protocol S Results

Anti-VEGF vs PRP Advantages to Treating NPDR Early

Anti-VEGF vs PRP Choosing Which Anti-VEGF to Use

Use Imaging to Inform Patients

Patient Case 1

Patient Case 1 (cont)

Patient Case 1 Follow-Up

Same-Day Referral to Retina

Patient Case 1 Diagnosis

Patient Case 1 Diagnosis (cont)

Patient Case 1 Diagnosis (cont)

Concluding Remarks

Abbreviations

Abbreviations (cont)